Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom

Nephrology Dialysis Transplantation

Volumn 32, Issue , 2017, Pages ii142-ii150

  Iwagami, Masao ^a   Tomlinson, Laurie A ^a   Mansfield, Kathryn E ^a   Casula, Anna ^b   Caskey, Fergus J ^b   Aitken, Grant ^c   Fraser, Simon D S ^d   Roderick, Paul J ^d   Nitsch, Dorothea ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UK RENAL REGISTRY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chronic kidney disease; Epidemiology; Primary care; Renal replacement therapy; Validity

Indexed keywords

CREATININE;

ADULT; AGE; ARTICLE; CREATININE BLOOD LEVEL; ELECTRONIC HEALTH RECORD; ENGLAND; ESTIMATED GLOMERULAR FILTRATION RATE; EXTERNAL VALIDITY; FEMALE; GENDER; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGISTER; RENAL REPLACEMENT THERAPY; UNITED KINGDOM; AGED; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADULT; AGED; ELECTRONIC HEALTH RECORDS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UNITED KINGDOM;

EID: 85019054783     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw318     Document Type: Article

References (35)

1. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272
2. Castro AF, Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009; 53: S46-S55
3. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives-A position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259
4. Liyanage T, Ninomiya T, Jha Vet al.Worldwide access to treatment for endstage kidney disease: a systematic review. Lancet 2015; 385: 1975-1982
5. National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. CG182. https://www.nice.org.uk/guidance/cg182 (1 March 2016, date last accessed)
6. Ackland P. Prevalence, detection, evaluation and management of chronic kidney disease. BMJ 2014; 348: f7688
7. Brück K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2015; 30: 6-16
8. Mc Cullough K, Sharma P, Ali T, et al. Measuring the population burden of chronic kidney disease: a systematic literature reviewof the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27: 1812-1821
9. Clinical Practice Research Datalink. http://www.cprd.com/intro.asp (1 March 2016, date last accessed)
10. de Lusignan S, van Weel C. The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 2006; 23: 253-263
11. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827-836
12. Herrett E, Thomas SL, Schoonen WMet al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14
13. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60: e128-e136
14. Health Survey for England-2010. Respiratory health: Chapter 8, Kidney disease and renal function. http://www.hscic.gov.uk/pubs/hse10report(1 March 2016, date last accessed)
15. Rao A, Casula A, Castledine C. UK Renal Registry 17th Annual Report: Chapter 2 UK renal replacement therapy prevalence in 2013: national and centre-specific analyses. Nephron 2015; 129(Suppl 1): 31-56
16. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997; 87: 36-40
17. Booth HP, Prevost AT, Gulliford MC. Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011. Pharmacoepidemiol Drug Saf 2013; 22: 1357-1361
18. Mathur R, Bhaskaran K, Chaturvedi N, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf) 2014; 36: 684-692
19. Kontopantelis E, Springate D, Reeves D, et al. Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework. BMJ 2014; 348: g330
20. Health Survey for England-2010. Respiratory health: Volume 2, Methods and documentation. http://www.hscic.gov.uk/pubs/hse10report(1 March 2016, date last accessed)
21. Fraser SD, Aitken G, Taal MWet al. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLOS One 2015; 10: e0118676
22. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
23. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047
24. Anderson J, Glynn LG. Definition of chronic kidney disease and measurement of kidney function in original research papers: a review of the literature. Nephrol Dial Transplant 2011; 26: 2793-2798
25. Davé S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009; 18: 704-707
26. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772
27. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150
28. Roderick PJ, Atkins RJ, Smeeth L, et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing 2008; 37: 179-186
29. Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: 950-960
30. Quality and Outcomes Framework. http://www.hscic.gov.uk/qof (1 March 2016, date last accessed)
31. Stevens PE, de Lusignan S, Farmer CK, et al. Engaging primary care in CKD initiatives: the UK experience. Nephrol Dial Transplant 2012; 27(Suppl 3): iii5-iii11
32. Fraser SD, Parkes J, Culliford D, et al. Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study. BMC Fam Pract 2015; 16: 18
33. Goodkin DA, Young EW, Kurokawa K, et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects.Am J Kidney Dis 2004; 44(5 Suppl 2): 16-21
34. de Lusignan S, Tomson C, Harris K, et al. Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract 2011; 117: c213-c224
35. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-Analysis. Lancet 2010; 375: 2073-2081